US venture capital fund focuses on Israel

Until numbers are calculated at year-end, venture capital professionals said there was no way to quantify affect of war on industry.

August 30, 2006 04:15
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


"One man's trash is another man's treasure," they say, so while some foreign investors may be shying away from Israel following the war in Lebanon, others are taking advantage of what they see as an opportunity. "Now is an excellent time to invest in Israel," said David Anthony, founder of 21Ventures, LLC, a NYC-based venture capital fund that has decided to shift its investment strategy focus primarily on Israeli start-ups as a result of the conflict. He feels a combination of factors creates a ripe environment for "angel investors" in the country. "My prediction is that as a result of the costs associated with Israel's military operations the budget for office of The Chief Scientist at the Israeli Ministry of Industry, Trade and Labor [the government body that assists with the development of new technologies in Israel] will be cut, which will create opportunity for our fund," explained Anthony. Anthony further remarked that "a derivative problem of war is that corporate investors are going to be more likely to avoid Israel so the supply of angel capital [private, early-stage equity financing] in Israel will decrease while the demand will remain." That is a void Anthony hopes to fill. Until the numbers are calculated at year-end, venture capital professionals said there was no way to quantify the affect of the war on the industry. "We do not expect a slowdown in direct investment in companies, but we do expect a slight slowdown in investment in venture capital funds," said Yoram Oron, founder and managing partner of Vertex Venture Capital and Chairman of the Israel Venture Association, an organization that represents the venture capital industry in Israel. Oron noted that during the second Intifada there was a similar decrease in foreign venture capital investments in the country. "Investing in Israel requires visiting Israel and during the war and the Intifada people cancelled their visits." Oron said that during the war some conferences and seminars were cancelled or moved overseas, but he expects that by the beginning of September business meetings in Israel will be back to normal levels.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection


Cookie Settings